Science for a better life

Latest News

For media enquiries please contact one of the following people:

Pharmaceuticals and Consumer Health: Michelle D'Heureux
Phone: +61 428 502 682

Crop Science and Animal Health: Lachlan Bird
Phone: +61 3 9248 6851

Bayer New Zealand: William Malpass
Phone: +64 9 441 8591

News

Monday - June 11, 2018

Phosphorus just the tonic for needy cows
Strong demand from vets and farmers // Highest amount of phosphorus available for nutritional supplementation More

Thursday - May 31, 2018

Treatment to tackle the country’s two leading causes of blindness now funded on the Pharmaceutical Schedule
EYLEA® (aflibercept) is available under PHARMAC funding from 1 June for the treatment of Wet Age Related Macular Degeneration (wet-AMD) and Diabetic Macular Oedema (DMO) More

Friday - May 25, 2018

Bayer is making good progress strategically
Acquisition of Monsanto expected to be closed in the near future / 2017 sales and earnings at the prior-year level / Dividend to be raised for the eighth time in succession – to 2.80 euros per share / Start to fiscal 2018 overshadowed by currency effects More

Thursday - May 03, 2018

Bayer Q1 2018: Operational business held back by currency effects – Major progress with Monsanto acquisition
Group sales increase by 2.0 percent (Fx & portfolio adj.) to 9.138 billion euros / EBITDA before special items down year on year due to currency effects / Net income declines by 6.2 percent to 1.954 billion euros / Core earnings per share down 1.3 percent at 2.28 euros / European Commission and additional regulators conditionally approve Monsanto acquisition / Currency adjusted Group outlook for 2018 confirmed More

Wednesday - April 04, 2018

Combining tradition with modernity:
Bayer hones its brand profile More

Wednesday - March 21, 2018

European Commission conditionally approves Bayerâ€™s proposed acquisition of Monsanto
Closing of transaction planned for the second quarter of 2018 More

Wednesday - February 28, 2018

Bayer: business at prior-year level â€“ on track with strategy
Group sales increased by 1.5 percent (Fx & portfolio adj.) to 35.015 billion euros / Another record year for Pharmaceuticals / Weak business development at Consumer Health / Crop Science business down against prior year due to situation in Brazil â€“ measures taking effect / EBITDA before special items level year on year at 9.288 billion euros / Net income raised by 61.9 percent to 7.336 billion euros / Core earnings per share increased by 1.0 percent to 6.74 euros / Covestro deconsolidated â€“ additional cash inflows of 4.7 billion euros / Monsanto acquisition expected to close in second quarter of 2018 / Group outlook for 2018: increase in sales (Fx & portfolio adj.), EBITDA before special items and core earnings per share at prior-year level due to currency effects More

Monday - December 04, 2017

Partnership a boost for rural health and wellbeing
Focus on rural youth health and suicide prevention // Collaboration key to success // $80,000 initial investment More

Wednesday - November 15, 2017

Heiko Schipper to join Bayer Board of Management and head Consumer Health Division
Erica Mann to leave Bayer effective March 31, 2018 More

Thursday - October 26, 2017

Bayer Q3 2017: Sales and earnings increased
Covestro deconsolidated / Group sales grow by 1.2 percent (Fx & portfolio adj.) to EUR 8,025 million / EBITDA before special items up by 4.1 percent to EUR 2,204 million / Net income of EUR 3,881 million including Covestro book profit More

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30